| INTRODUC TI ON
The global shortage of donated human organs and tissues has motivated efforts to genetically engineer pigs as a source of xenografts for human patients. A major advance in overcoming the immunological hurdles involved was identification of galactose-α1,3-galactose (α-1,3Gal) as responsible for eliciting hyperacute rejection of pig tissue by old world primate recipients. Binding of preformed antibodies activates the host complement system leading to complete destruction of the xenograft within minutes. 1 Removing the main enzyme responsible for α-1,3Gal synthesis by inactivating the porcine GGTA1 gene significantly reduces hyperacute rejection, and this can be further improved by equipping GGTA1-knockout pigs with human complement regulator transgenes. [2] [3] [4] [5] [6] The focus has now shifted onto delayed immune responses, notably those that target the endothelial lining of the graft vasculature. Acute vascular rejection occurs within a few days or weeks and is characterized by proinflammatory and procoagulatory activation of the vascular endothelium, complement activation, thrombotic microangiopathy and infiltration of innate immune cells into the graft. 7, 8 This response is also initiated by preformed antibodies, 9 with evidence indicating a role for non-Gal porcine antigens including N-glycolylneuraminic acid (Neu5Gc), synthesized by cytidine monophospho-N-acetylneuraminic acid hydroxylase (CMAH), [10] [11] [12] and surface glycans including the Sd(a) blood group antigen produced by β-1,4-N-acetyl-galactosaminyl transferase 2 (B4GALNT2). [13] [14] [15] Triple knockout of porcine GGTA1, CMAH and B4GALNT2 has been shown to significantly reduce human IgG and IgM antibody binding to porcine peripheral blood monocytes and red blood cells. [15] [16] [17] These studies also revealed that human leucocyte antigen (HLA) antibodies cross-react with the porcine major histocompatibility complex class I, also known as swine leucocyte class I (SLA-I) antigens, highlighting the SLA-I complex as a potential target for further genetic modification. 17 SLA class I molecules consist of a heavy α-chain and a light β-chain (β2-microglobulin; B2M). The α-chain, a transmembrane glycoprotein with three domains (α1, α2 and α3), is encoded by three different genes SLA-1, -2 and -3. 18 There are also a number of pseudogenes.
The α1 and α2 domains interact to form the peptide-binding domains and are therefore highly polymorphic. The α3 domain contains the cytoplasmic tail and has a constant region (encoded by exon 4) that is conserved between SLA-1, -2 and -3. β2-microglobulin does not contain a transmembrane region, is non-covalently linked with the α-chain and encoded by a highly conserved gene (B2M). 19 SLA-I has previously been ablated by targeting either porcine B2M, 20 or the conserved region of the α-chain within exon 4. 21 To minimize antibody-mediated xenograft rejection mechanisms, we produced pigs carrying four-fold knockout of GGTA1, CMAH, B4GALNT2 and either the SLA-I heavy α-chain or light β-chain, and assessed how these affected binding of human IgG and IgM. The four-fold knockouts were also combined with a five-fold (human CD46, CD55, CD59, HO1 and A20) transgenic genotype, generated previously and shown to reduce hyperacute and acute vascular rejection, 5 and the effects on C3b/c and C4b/c complement activation tested. 
| MATERIAL S AND ME THODS

| Animal welfare
| Generation of guide RNA constructs
Specific gRNA oligonucleotides for GGTA1 exon 7 (5′-GTC GTGACCATAACCAGA-3′), CMAH exon 10 (5′-AGAAACTCCTGAA CTACA-3′), B4GALNT2 exon 3 (5′-AGGAAAGCTATAACTTGG-3′) and B2M exon 1 (5′-TAGCGATGGCTCCCCTCG-3′) or SLA-I αchain exon 4 (guide 1 5′-CCAGGACCAGAGCCAGGACA-3′ and guide 2 5′-CCAGAAGTGGGCGGCCCTGG-3′), 21 18 to 20 bp in length with additional BbsI overhangs were synthesized by MWG Eurofins, Germany. gRNA oligonucleotides were sub-cloned into plasmid pSL1180 that carries a 0.2 kb U6 promoter followed by a BbsI restriction site and gRNA scaffold sequences. Restriction fragments were further sub-cloned into the pX330 plasmid backbone (pX330-U6-Chimeric_BB-CBh-hSpCas9 was a gift from Feng Zhang; Addgene plasmid # 42230; http://n2t.net/addge ne:42230 ; RRID:Addgene_42230). The two final constructs contained three gRNAs specific for GGTA1, CMAH and B4GALNT2; either an alone reduced C3b/c and C4b/c complement activation to such an extent that further knockouts had no significant additional effect.
Conclusion:
We showed that pigs carrying several xenoprotective transgenes and knockouts of xenoreactive antigens can be readily generated and these modifications will have significant effects on xenograft survival.
K E Y W O R D S
B2M, B4GALNT2, CMAH, complement regulators, GGTA1, MHC-I, multiplex CRISPR/Cas9 gene editing, SLA-I, xenotransplantation additional gRNA specific for B2M, or two additional gRNAs for the SLA-I α-chain; a 0.8 kb chicken β hybrid promoter, followed by a SV40 nuclear localization signal (NLS), a 4.0 kb hSpCas9 gene followed by a second NLS signal, linked via a T2A self-cleaving peptide to a 0.6 kb puromycin resistance cassette with a 0.2 kb bovine growth hormone polyadenylation (BGHpA) signal. A summary of the knockout strategy is provided in Figure S1 . An alignment of SLA-1, SLA-2 and SLA-3 of exon 4 with the sgRNA target site is provided in Figure S2 . Details of screening primers for the genomic target sites are provided in Table S1.
| Cell culture
Porcine kidney fibroblasts (PKF) were isolated and cultured as described previously. 5 Transfection of gRNA/Cas9 plasmids was performed using Lipofectamine 2000 (Life Technologies). Twenty-four hours after transfection, transiently transfected cells were selected using 1.5 µg/mL puromycin (InvivoGen) for 2 days.
| Magnetic bead selection and sequencing
α-1,3Gal-deficient cells were enriched by counter-selection using streptavidin-coated magnetic beads (Dynabeads, Life Technologies) and biotin-conjugated isolectin B4 (Enzo Life Science) in a magnetic field. Gene editing was determined by sequencing across the gRNA target site (MWG Eurofins) and subsequent TIDE (tracking of indels by decomposition) analysis. 22 
| Somatic cell nuclear transfer
Nuclear transfer was performed as described previously. 5 In short, donor cells were arrested at GO/G1 phase by serum deprivation.
Oocytes isolated from prepubertal gilts were matured in vitro, enucleated, single donor cells were inserted in the perivitelline space, and then cell fusion and oocyte activation induced by electric pulse.
Reconstructed embryos were transferred into the oviducts of hormonally synchronized recipient gilts by mid-ventral laparotomy. Pietsch, University of Bonn) and anti-human CD4 (OKT4, ATCC). Cell cultures and proliferation assays were performed with RPMI-1640 medium (Lonza) supplemented with 10% FCS, 2 mmol/L L-glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin, 1 mmol/L sodium pyruvate and 0.05 mmol/L β-mercaptoethanol. Cells were cultivated at 5% CO 2 and 37°C for human PBMC or 39°C for porcine PBMC. 
| Isolation and culture of peripheral blood mononuclear cells
| Flow cytometry
| Western blot analysis
Protein isolation and Western analysis were carried out as described previously. 5 Neu5Gc epitopes were detected using a purified chicken anti-Neu5Gc antibody (clone Poly21469 chicken IgY; diluted 1:10 000 in Neu5Gc free blocking solution) and horseradish peroxidase-labelled goat anti-chicken sc-2428 (diluted 1:5000 in Neu5Gc free blocking solution). GAPDH was detected using mouse monoclonal anti-GAPDH #G8795, (diluted 1:3000) and rabbit anti-mouse IgG H&L (HRP) ab6728 (diluted 1:5000).
| Immunohistochemistry
Immunohistochemistry was performed as described previously. 23 Tissues were snap-frozen in liquid nitrogen. Five-micrometre cryostat sections were air-dried, acetone fixed and incubated with mouse anti-pig MHC class I mAb 74-11-10 24 (provided by A.
Saalmüller), or mouse anti-human beta2 microglobulin mAb B2M-02 (Thermo Fisher Scientific), then horseradish peroxidase-coupled goat anti-mouse antibody (Dianova) and binding visualized with 3amino-9-ethyl-carbazole (AEC, Sigma). Sections were lightly counterstained with haematoxylin (Merck). Cells were stained using biotinylated anti-porcine MHC-I (diluted 1:100; PT85A, Kingfisher Biotech), biotinylated mouse anti-human beta2 microglobulin mAb B2M-02 (diluted 1:100; Thermo Fisher Scientific) and Atto-488 streptavidin (diluted 1:1000; ATTO-TEC). 
| Cell proliferation
| Construction of microfluidic channels with round cross section
Microfluidic channels were prepared as described previously. 25 In 
| PDMS coating and cell seeding in microfluidic channels
The luminal surface of the microchannels was coated using human fibronectin (Millipore) and bovine collagen I (Gibco, Thermo Fisher Scientific), as described previously. 25 
| Human serum preparation
Human blood was drawn from healthy volunteers into polypropylene tubes containing glass beads (S-Monovette, Sarstedt) and allowed to clot for 30 minutes at room temperature. The clot was removed by centrifugation for 10 minutes, 2000 × g, 4°C and the supernatant collected and stored at −80°C. All human blood samples were obtained with informed consent according to Swiss jurisdiction and the ethics guidelines of the Bern University Hospital.
| Perfusion of PKFs with normal human serum
A peristaltic pump (Minipuls 3 with 8 channels, Gilson) was connected to the PKF-coated microfluidic channels via sterile silicon tubing with stoppers (Gilson) and extension silicon tubes (Gobatec).
The tubing circuit was previously autoclaved and flushed extensively with distilled water, then PBS followed by cell culture medium with 4% dextran. Reservoir tubes of 15 mL (Nalge NUNC) were filled with 10 mL of either serum-free DMEM for controls, or 10% normal human serum in serum-free DMEM and connected to each microchannel. PKF-coated microchannels were perfused at 1 rpm corresponding to a flow rate of 0.09 mL/min in an incubator at 37°C/ 5% CO 2 for 2 hours. Perfusion was in a closed circuit to recirculate the perfusate.
| Immunoglobulin binding and complement deposition assessment
Immunofluorescence staining was performed to assess the bind- 
| RE SULTS
We adopted two approaches to removing the key porcine xenoreactive antigens and porcine SLA-I from the cell surface. Both used multiplex genome editing to introduce inactivating mutations into GGTA1, CMAH and B4GALNT2, while surface porcine SLA-I expression was blocked by targeting either the light β-chain (B2M) or the constant region of the heavy α-chain.
| Generation of pigs with gene-edited GGTA1, CMAH, B4GALNT2 and B2M
Fourteen porcine kidney fibroblast cell clones selected for lack of α-1,3Gal were analysed by DNA sequencing to detect allele-specific mutations of GGTA1, CMAH, B4GALNT2 and B2M. Twelve clones Figure 1A) . The number of alleles detected for B2M accorded with previous reports. 20, 26 The complete indel sequences of all mutated alleles are attached in Figure S3 .
| Multiplex gene editing results in functional inactivation of GGTA1, CMAH, B4GALNT2 and B2M
While most gene editing events resulted in frameshift or premature stop codons, one CMAH allele showed the loss of a single and SLA-I antigens was confirmed by flow cytometry ( Figure 1C ).
Because Neu5Gc can be transmitted by serum components to
Neu5Gc-deficient cells during cultivation, ear fibroblasts from piglet 90 were also cultured in xenoserum-free conditions (serum replacement or chicken serum); however, the cells did not proliferate and could not be used for Neu5Gc flow cytometry analysis.
Piglet 90 suffered from an infection at age 6 weeks and had to be sacrificed. Necropsy examination revealed no abnormalities other than an enlarged spleen due to the infection. Tissue samples were collected and Western blot analysis performed to verify the absence of Neu5Gc epitopes ( Figure 1D ).
| Generation of pigs with gene edited GGTA1, CMAH, B4GALNT2 and constant region of the SLA-I heavy α-chain
For the inactivation of GGTA1, CMAH, B4GALNT2 and SLA-I heavy α-chain, a puromycin-selected pool was used to enrich α-1,3 F I G U R E 2 A, Genotypic analysis of four-fold knockout (SLA-I heavy) piglets 10261 and 10262. PCR and subsequent sequencing of the target sites for GGTA1, CMAH, B4GALNT2 and SLA-I revealed several indels. A1: allele one, A2: allele two, WT: wild-type. Both pigs showed an identical indel pattern. For SLA-I, a PCR fragment could only be amplified for SLA-1. B, Flow cytometry analysis of PBMC. Total cell count was 10 000. Maximum peak at 250-750 cells. X axis from 1 to 10 4 . Wild-type PBMC from animals 10269, 10270 and 10274 served as controls. Flow cytometry measurements revealed the absence of α-1,3Gal (GGTA1), Neu5Gc (CMAH), Sd(a) (B4GALNT2) and SLA-I (antibody: PT85A). Light grey histograms represent unstained controls, dark grey histograms represent secondary antibody staining only and squared histograms represent isotype controls. 1 × 10 5 purified human CD8 + T cells (C) or human PBMC (D) were stimulated with increasing numbers of irradiated (30 Gy) porcine PBMC from four-fold knockout pig 10261 or a wild-type pig. Proliferation was measured after 5 d + 16 h by 3 Hthymidine incorporation. Data represent mean cpm ± SEM of triplicate cultures obtained with cells from one human blood donor in a single experiment. Similar response patterns were observed using responder cells from a second blood donor and stimulator cells from four-fold knockout pig 10262. Proliferation of human CD8 + T cells decreased after stimulation with four-fold knockout porcine PBMC Gal-deficient cells via magnetic bead selection. Sequencing across the gRNA target sites revealed indel efficiencies of 99% for GGTA1 and up to 81% for the other targeted genes. The cell pool was used for somatic cell nuclear transfer. A total of 436 reconstructed embryos were transferred into three recipients, and one pregnancy was established and two live-born piglets obtained (10261 and 10262).
Tail samples were collected and DNA isolated. PCR amplification and subsequent sequencing of the target sites revealed bi-allelic indel mutations in all four genes (Figure 2A ). Both pigs showed the same indel pattern and thus probably originated from the same cell clone.
The target site of GGTA1 exon 7 showed a bi-allelic 1 bp insertion.
The target site of CMAH exon 10 revealed a 4 bp deletion in one allele and a 22 bp deletion, 6 bp mutation in the other. B4GALNT2 showed a 1 bp insertion in both alleles. Analysis of SLA-I was only possible for SLA-1 because several PCR primer combinations failed to amplify a PCR fragment from SLA-2 and SLA-3 ( Figure S4) , even though the original wild-type cells did amplify fragments. Thus, the most likely reason is a deletion that either removed SLA-2 and SLA -3 sequences or at least the primer-binding site(s). Analysis of SLA-1 exon 4 revealed a 1 bp deletion and 58 bp inversion. The complete indel sequence of all mutated alleles can be found in Figure S3 .
Loss of α-1,3Gal (GGTA1), Neu5Gc (CMAH), Sd(a) (B4GALNT2) and SLA-I epitopes (detection of SLA-1, SLA-2 and SLA-3 by the antibody used) was confirmed by flow cytometry analysis of PBMC from piglets 10261 and 10262 ( Figure 2B ).
| CD8 + T-cell response
As human T cells can be activated by porcine cells, a direct interaction between porcine MHC molecules and the human T-cell receptor was assumed. 27 Absence of SLA-I from porcine cells should therefore lead to decreased activation, especially of human CD8 + T cells. We tested the potential of PBMC from the four-fold knockout pigs 10261 and 10262 to induce proliferation of either isolated purified hCD8 + T cells, or total PBMC from human blood donors.
Using purified hCD8 + T cells as responders, almost no proliferation was observed after coculture with four-fold knockout porcine cells, compared to a strong proliferative response after stimulation with wild-type porcine cells ( Figure 2C ). In contrast, only a non-significant difference was observed in the proliferative response of the whole human PBMC population stimulated with wild-type or four-fold knockout cells. The strong proliferating response of hCD4 + T cells seemed to obscure any effect on hCD8 + T cells in this culture assay ( Figure 2D ).
| Immunohistology
Cell and tissue samples were also used to carry out immunohistology for B2M and SLA-I antigens, see Figure 3 and Figure S5 . 
| Analysis of off-target events
We screened for five of the most probable off-target sites for each of the guide RNAs, as predicted by the program CRISPOR (crispor.tefor. net). Details of screening primers and off-target sites are provided in Table S2 . No off-target events were detected for the guide RNAs 
| Effect of removing different xenoreactive epitopes combined with expression of complement regulator genes on antigen deposition
To evaluate the effects of different knockout combinations on human IgG and IgM binding, we perfused porcine kidney fibroblasts previously isolated from our breeding animals that carried CMAH knockout, CMAH/GGTA1 double knockout, CMAH/GGTA1/B4GALNT2/B2M fourfold knockout (piglet 90) and wild-type controls, each between passage 5 to 10 and cultured in artificial round section microvessels perfused with normal human serum. CMAH and CMAH/GGTA1 knockout cells showed significantly reduced human IgG and IgM binding compared to wild type, but four-fold knockout cells showed the strongest total reduction ( Figure 4A and B) . As antibody binding leads to complement activation, we also used the microfluidic system to evaluate the effect of combining four-fold knockout with strong expression of complement regulatory transgenes. For this, multiplex genome editing was carried out in kidney fibroblasts, passage 5 to 10, from multi-transgenic pigs (human CD46, CD55, CD59, HO1 and A20). 5 The knockout profile of these cells was analysed after selection and enrichment by TIDE analysis and indicated almost 100% editing efficiency for each of these four genes. The five-fold transgenic cells showed significant reduction in C3b/c and C4b/c activation even in the absence of GGTA1 knockout.
Inclusion of GGTA1 knockout to this multi-transgenic background reduced complement activation to a minimum. This reduction was so marked that further effects of the four-fold knockout could not be discerned ( Figure 4C 
| D ISCUSS I ON
Removal of xenoreactive porcine carbohydrate antigens combined with expression of xenoprotective transgenes holds the promise of protecting xenografts against immune rejection in the short and medium term. The most effective combination of knockouts and transgenes does however remain to be identified and will likely be informed by clinical findings. Previously, we showed that multiple transgenes could be combined and placed at a single genetic locus. 5, 23 Here we show that multiple xenoreactive antigens can be inactivated simultaneously and, if required, multi-modified cells can be used to generate viable pigs.
We chose to combine a three-fold knockout of genes responsible for major xenoreactive sugar antigens plus knockout of the While, as previously demonstrated, the three-fold knockout provided beneficial reduction of human immunoglobulin binding, 14, 17 but this was further improved by removing surface SLA-I antigens responsible for HLA cross-reactivity. 17 We chose to inactivate the light β-chain (B2M) or heavy α-chain of SLA-I. Although negative effects of B2M knockout concerning iron homeostasis have been reported in mice, 29 we obtained viable pigs by both methods. Which form of SLA-I inactivation is the best is open to question. It has been shown in mice that B2M-independent assembly of the heavy α-chain with peptides, 30 stably expressed at the cell surface 31 and interaction with CD8 + T cells, is possible. 30 However, we did not detect cell We previously showed that multiple transgenes can be combined and placed at a single genetic locus; here we show that multiple xenoreactive antigens can be inactivated simultaneously and viable pigs generated. This allows fast track generation of xenodonor pigs once the most effective combination of gene addition and inactivation has been determined. Such an approach also lends itself to the generation of different pig lines each with a set of genetic modifications tailored to the transplantation of particular organs or tissues.
F I G U R E 4 Incubation of wild-type and various knockout porcine cells with human serum using microfluidic channels. A, Binding of human IgG antibodies. Mean ± SD. Numbers of replicates of each group as shown on X axis: N = 5, 5, 5, 5, 5, 7, 5, 5. B, Binding of human IgM antibodies. Mean ± SD. N = 5, 5, 10, 10, 10, 10, 5, 5. C, C3b/c complement activation. Mean ± SD. N = 5, 5, 5, 3, 5, 3, 5, 5. D, C4b/c complement activation. Mean ± SD. N = 5, 5, 5, 4, 5, 3, 5, 5. Micrographic images are on the right side. NHS: normal human serum; 5xtg: cells isolated from pigs expressing CD46, CD55, CD59, HO1 and A20; 4xKO: cells isolated from pigs with inactivation of GGTA1, CMAH, B4GALNT2 and B2M. The 4xKO was performed on 5xtg cells 
